R EFRESH OPTIVE   MEGA - 3 PF ® Drug Facts

Refresh Optive Mega-3 PF by

Drug Labeling and Warnings

Refresh Optive Mega-3 PF by is a Otc medication manufactured, distributed, or labeled by Allergan, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

REFRESH OPTIVE MEGA-3 PF- carboxymethylcellulose sodium, glycerin, polysorbate 80 solution/ drops 
Allergan, Inc.

----------

REFRESH OPTIVE MEGA-3 PF®
Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%

Glycerin 1%

Polysorbate 80 0.5%

Purpose

Eye lubricant

Eye lubricant

Eye lubricant

Uses

  • For the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun.
  • May be used as a protectant against further irritation.

Warnings

  • For external use only.
  • To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
  • If solution changes color, do not use.

Stop use and ask doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Prior to first use, please read the “Instructions for Use” inside this carton.
  • Instill 1 or 2 drops in the affected eye(s) as needed.

Other information

  • Use only if tape seals on top and bottom flaps are intact.
  • Use before expiration date marked on container.
  • Discard 90 days after opening.
  • Store at 59°-77°F (15°-25°C).
  • RETAIN THIS CARTON FOR FUTURE REFERENCE

Inactive ingredients

Boric acid; butylated hydroxyl toluene; carbomer copolymer type A; castor oil; erythritol; flaxseed oil; levocarnitine; polyoxyl 40 stearate; purified water; and trehalose. May contain hydrochloric acid and/or sodium hydroxide (to adjust pH).

Questions or comments?

1.800.678.1605

refresheyedrops.com

PRESERVATIVE-FREE MULTIDOSE BOTTLE

BUILT-IN DOUBLE LOCKOUT SYSTEM KEEPS DROPS STERILE.

©2024 AbbVie. All rights reserved.
All trademarks are the property of their respective owners.

Distributed by: AbbVie, Inc.,
North Chicago, IL 60064

Product of US

Patented. See abbvie.com/patents

PRINCIPAL DISPLAY PANEL

NDC: 0023-3988-10

NEW
PRESERVATIVE-FREE

Refresh
OPTIVE
MEGA-3® PF
Lubricant Eye Drops

with Hydrocell®

Fast-Acting Dry Eye Relief

Enhanced With
Flaxseed Oil*

0.33 fl oz (10 mL) Sterile

PRINCIPAL DISPLAY PANEL
NDC: <a href=/NDC/0023-3988-10>0023-3988-10</a>
NEW 
PRESERVATIVE-FREE

Refresh
OPTIVE
MEGA-3® PF
Lubricant Eye Drops

with Hydrocell®

Fast-Acting Dry Eye Relief

Enhanced With
Flaxseed Oil*

0.33 fl oz (10 mL) Sterile

REFRESH OPTIVE MEGA-3 PF 
carboxymethylcellulose sodium, glycerin, polysorbate 80 solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 0023-3988
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM5 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN10 mg  in 1 mL
POLYSORBATE 80 (UNII: 6OZP39ZG8H) (POLYSORBATE 80 - UNII:6OZP39ZG8H) POLYSORBATE 805 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
CARBOMER COPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 71DD5V995L)  
CASTOR OIL (UNII: D5340Y2I9G)  
ERYTHRITOL (UNII: RA96B954X6)  
LINSEED OIL (UNII: 84XB4DV00W)  
LEVOCARNITINE (UNII: 0G389FZZ9M)  
POLYOXYL STEARATE 40 (UNII: 13A4J4NH9I)  
WATER (UNII: 059QF0KO0R)  
TREHALOSE (UNII: B8WCK70T7I)  
Other Ingredients
Ingredient KindIngredient NameQuantity
May containHYDROCHLORIC ACID (UNII: QTT17582CB)  
May containSODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 0023-3988-101 in 1 CARTON02/15/202502/15/2025
110 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01802/15/202502/15/2025
Labeler - Allergan, Inc. (144796497)

Revised: 2/2025
 

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.